CorMedix
CRMD
#6079
Rank
A$1.40 B
Marketcap
A$17.88
Share price
-3.23%
Change (1 day)
32.75%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2025 (TTM): A$0.16 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$28.84 Million, an increase over its 2023 earnings that were of -A$69.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.16 B-672.88%
2024 -A$28.84 Million-58.3%
2023 -A$69.15 Million53%
2022 -A$45.2 Million2.81%
2021 -A$43.96 Million8.32%
2020 -A$40.59 Million26.53%
2019 -A$32.08 Million-19.89%
2018 -A$40.04 Million-18.72%
2017 -A$49.26 Million34.56%
2016 -A$36.61 Million34.88%
2015 -A$27.14 Million-11.08%
2014 -A$30.52 Million124.69%
2013 -A$13.59 Million144.91%
2012 -A$5.55 Million-48.41%
2011 -A$10.76 Million-33.29%
2010 -A$16.12 Million78.42%
2009 -A$9.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.80 B 1,658.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.24 B 54.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$21.81 M-86.34%๐Ÿ‡บ๐Ÿ‡ธ USA